No Detail Found!

Comparative study of oral antidiabetic medications on the Rat Model

Author(s)
Patience Nwonu Department of Pharmacology & Toxicology, Faculty of Pharmaceutical Sciences, University of Nigeria, Nsukka, P.M.B. 410001, Enugu, Enugu State, Nigeria
Chukwunwike Nwonu Department of Pharmacology & Therapeutics, Faculty of Basic Clinical Sciences, College of Health Sciences, Rev. Fr. Moses Orshio Adasu University, P.M.B. 102343, Makurdi, Benue State, Nigeria
Bonaventure Obi Department of Pharmacology & Toxicology, Faculty of Pharmaceutical Sciences, University of Nigeria, Nsukka, P.M.B. 410001, Enugu, Enugu State, Nigeria
Theophine Akunne Department of Pharmacology & Toxicology, Faculty of Pharmaceutical Sciences, University of Nigeria, Nsukka, P.M.B. 410001, Enugu, Enugu State, Nigeria
Chisom Ekeugo Department of Pharmacology & Toxicology, Faculty of Pharmaceutical Sciences, University of Nigeria, Nsukka, P.M.B. 410001, Enugu, Enugu State, Nigeria
Adaobi Ezike Department of Pharmacology & Toxicology, Faculty of Pharmaceutical Sciences, University of Nigeria, Nsukka, P.M.B. 410001, Enugu, Enugu State, Nigeria
Abstract
Introduction: In recent times, comparing the effects of oral antidiabetic agents as monotherapy or in combination in controlling diabetes mellitus and other related complications has become increasingly apparent. The study examined the effects of acarbose (AC), pioglitazone (PGZ), and vildagliptin (VDG) on glycaemic control, as well as on biochemical indices in an alloxan-induced diabetic rat model. Materials and Methods: Adult Wistar rats were induced with diabetes through the alloxan monohydrate (100 mgkg-1; i.v.) administration. Five (5) groups of rats were utilized (n=6); group 1 filled in as the normal control, group 2 filled in as diabetic control group 3, while 4 and 5 were the diabetic experimental groups that got 30 mgkg-1day-1 of AC, PGZ, and VDG. Results: The study analysed the effects of aspartate aminotransferase (AST), agents on blood glucose, low-density lipoprotein (LDL-C), alanine aminotransferase (ALT), high-density lipoprotein, total cholesterol (TC), alanine phosphatase, and triacylglycerol (TAG) activities. In diabetic rats administered AC (P<0.05), the result demonstrated [VDG (P<0.05) and PGZ (P>0.05)] marked decreases in the blood glucose levels. The serum TC, LDL-C, and TAG levels were significant in the AC (P<0.05) and VDG (P<0.05) groups, and were additionally decreased in every treated group, the serum TAG level was insignificantly (P>0.05) diminished in diabetic rats administered PGZ. Likewise, in every single treated group compared with the diabetic control group, ALP, AST, and ALT were significantly (P<0.05) reduced. Conclusion: The administration of AC, PGZ, and VDG displayed significant improvement in the biochemical indices altered during diabetic-related manifestations in the experimental subjects. However, VDG demonstrated superior anti-hyperglycaemic adequacy.
Publication Details
Page(s) 113-118
Published Journal: Bioscience Research, Volume: 22, Issue: 2, Year: 2025

Request the full text from PASTIC

Keywords
Alloxan, Alloxan, Diabetes Mellitus, blood glucose, lipoproteins, Liver enzymes, Diabetes mellitus, Diabetes mellitus
References
Abou-Shoer M .2010 .A simple calorimetric method. American Journal of Analytical Chemistry, 1 : 12012.
Ahrén B,Foley J .2008 .The islet enhancer vildagliptin: mechanisms of improved glucose metabolism. International Journal of Clinical Practice, 62(159) : 8-14.
Alemu F .2015 .Prevalence of diabetes mellitus disease and its association with level of education among adult patients attending at Dilla Referral Hospital, Ethiopia. Journal of Diabetes and Metabolism, 6 : 521.
Aulbach AD,Amuzie CJ .2017 .A comprehensive guide to toxicology in non-clinical drug development. 2nd Edition, : 447-471.
Azizi R,Goodarzi Z,MT Z .2014 .Effect of Biochanin-A on serum visfatin levels in STZ-induced diabetic rats. Iran Red Crescent Medical Journal, 16(9) : 1-7.
Cernea S and Raz I .2011 .Therapy in the early stage: incretins. Diabetes Care. 34 Suppl, : S264-S271.
Chamberlain JJ,Herman WH,Leal S,Rhinehart AS .2017 .Pharmacological therapy for type 2 diabetes: Synopsis of the 2017 American Diabetes Association Standards of Medical Care in Diabetes. Annals of Internal Medicine, 166(8) : .
Cheatham WW .2010 .Peroxisome proliferator-activated receptor translational research and clinical experience. American Journal of Clinical Nutrition, 91 : 262S-e266S.
Danaei G,Finucane MM,Lu Y,Singh GM,Cowan MJ,Paciorek CJ,Lin JK,Farzadfar F,Khang Y,Stevens GA,Rao M,Ali MK,Riley LM,Robinson CA,Ezatti M .2011 .global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet, 378 : 31-40.
Godinho R,Mega C,Teixeira de Lemos E,Carvalho E,Teixeira F,Fernandes R,Reis F .2015 .. , : .
0

Citations

0

Downloads

54

Views